Black checkmark with a sparkle and a curved line underneath on a white background.
Company

NON INVASIVE MONITORING SYSTEMS INC /FL/

Ticker
NIMU
Sector
Industry
Report date
November 16, 2026
Valye AI Score

90

Very high visibility
Recent developments
Recent developments summary

Recent news coverage does not relate to Non Invasive Monitoring Systems, Inc.'s business or operations and includes general market and unrelated company news.

Recent developments:
  • Recent news items primarily cover general market activity and unrelated companies, with no direct information about Non Invasive Monitoring Systems, Inc.'s business or developments [N1][N2][N3][N4][N5].
Overview

Non Invasive Monitoring Systems, Inc. (NIMS) was incorporated in Florida in 1980 and historically developed and sold non-invasive therapeutic acceleration platforms designed to temporarily increase local circulation and relieve minor aches and pains. The company discontinued operations in May 2019 and currently operates as a shell company with no products or inventory. Financial disclosures indicate ongoing net losses, limited liquidity, and substantial doubt about the company’s ability to continue as a going concern without additional financing. The company’s common stock trades on the OTC PINK market as a penny stock with low liquidity and price volatility.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. Non Invasive Monitoring Systems, Inc. is a shell company with discontinued operations since 2019. The company has no current products or inventory and has reported ongoing net losses and negative working capital. Recent SEC filings show limited liquidity and continued operating losses. The company’s common stock trades as a penny stock on the OTC PINK market with low liquidity and volatility. Recent news coverage is unrelated to the company’s business.

Scenarios for NIMU

Bull case model:

The company’s historical expertise in non-invasive therapeutic devices could provide a foundation for future business activities if operations were to resume and new products developed. The existing corporate structure and intellectual property might offer some value if leveraged or acquired.

Bear case model:

The company has discontinued operations, lacks products and inventory, and faces substantial doubt about its ability to continue as a going concern. It has ongoing net losses, negative working capital, and limited liquidity. The absence of an independent audit committee and governance weaknesses add to operational risks. The penny stock status and low liquidity of its common stock may limit investor interest and market activity.

Moat:

The company currently has no active business operations, products, or inventory, and thus does not possess a competitive moat. Its historical product offerings were niche therapeutic devices, but with discontinued operations since 2019, there is no ongoing competitive positioning or market presence.

Risks overview
Risks summary
The primary risk is the company’s substantial doubt about its ability to continue as a going concern due to ongoing losses, limited liquidity, and discontinued operations.
Risks details:

• Going Concern Risk: The company has a history of operating losses, negative working capital, and substantial doubt exists about its ability to continue as a going concern without additional financing.
• Liquidity Risk: As of September 30, 2026, the company had very limited cash and current assets relative to current liabilities, resulting in low liquidity ratios (current ratio 0.06, cash ratio 0.09).
• Lack of Business Operations: The company discontinued operations in 2019 and currently has no products or inventory, limiting its ability to generate revenue or cash flow.
• Governance Risk: The company lacks an independent audit committee and compensation committee, which may impair oversight and increase operational risks.
• Penny Stock and Market Liquidity Risk: The company’s common stock trades as a penny stock on the OTC PINK market with low liquidity and significant price volatility, which may affect investor ability to trade shares.

FINAL FORECAST FOR NIMU

Final take one line
Non Invasive Monitoring Systems, Inc. is a shell company with discontinued operations, limited liquidity, and no current business activity, resulting in low visibility into its business model.
Final take 12 to 24 month view

Business trends: The company has ceased operations since 2019 and has no current products or revenue generation.
Execution milestones: The company has filed recent SEC reports but remains a shell with no active business; efforts to maintain compliance with reporting obligations continue.
Key risks: Substantial doubt about going concern status, limited liquidity, lack of business operations, governance weaknesses, and penny stock market risks.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

90
LLM visibility overview
LLM Visibility known facts
  • Non Invasive Monitoring Systems, Inc. (NIMS) was incorporated in Florida in 1980 and is headquartered in Miami, Florida.
  • The company’s primary business historically involved research, development, manufacturing, marketing, and sales of non-invasive, motorized, whole body periodic acceleration (WBPA) platforms intended to temporarily increase local circulation for relief of minor aches and pains, muscle relaxation, and reduce morning stiffness.
  • Operations were effectively discontinued in May 2019, and the company is currently a shell company as defined under SEC rules.
  • As of the latest filings, the company has no inventory and no products available for sale.
  • The company has a history of operating losses and substantial accumulated deficit ($29.0 million as of July 31, 2025).
  • The company reported net losses of $222,000 and $113,000 for fiscal years ended July 31, 2025 and 2024, respectively.
  • As of July 31, 2025, the company had only $3,000 in cash and negative working capital of approximately $947,000.
  • The company’s consolidated financial statements are prepared on a going concern basis but with substantial doubt about its ability to continue as a going concern absent additional financing.
  • The company will require additional funding to continue operations, which may not be available on acceptable terms or at all.
  • The company has experienced delays in SEC filings but expects to become current with reporting obligations.
  • The company lacks an independent audit committee and compensation committee, which may affect governance and oversight.
  • The company’s common stock trades as a penny stock on the OTC PINK market, with low liquidity and significant price volatility.
  • Recent SEC filings as of September 30, 2026, show cash and equivalents of $160,000, current assets of $117,000, and current liabilities of $1,842,000, resulting in a current ratio of 0.06 and cash ratio of 0.09, indicating very limited liquidity.
  • The company reported a net loss of $282,000 and basic and diluted EPS of -$0.27 for the quarter ended September 30, 2026.
  • The company’s last reported revenue was $6,000 for the fiscal year ended July 31, 2018, with no recent revenue disclosed.
  • Recent news coverage does not pertain to the company’s business or operations and includes general market and unrelated company news.
Sources
Sources - Context summary

Generated 2026-11-16

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-01-30 | 10-K
  • S2 | 2026-11-16 | 10-Q
Sources - News headlines
  • N1 | 2026-11-16 | www.nasdaq.com | Corn Posting Midday Gains | https://www.nasdaq.com/articles/corn-posting-midday-gains-0
  • N2 | 2026-11-16 | www.nasdaq.com | Soybeans Posting Midday Losses, Despite Record NOPA Crush | https://www.nasdaq.com/articles/soybeans-posting-midday-losses-despite-record-nopa-crush
  • N3 | 2026-11-16 | www.nasdaq.com | Invivyd, Inc. Reports Q3 2026 PEMGARDA Net Product Revenue of $15.4 million | https://www.nasdaq.com/articles/invivyd-inc-reports-q3-2026-pemgarda-net-product-revenue-154-million
  • N4 | 2026-11-16 | www.nasdaq.com | VNET Group, Inc. Appoints Fuqiang Wang to Board of Directors, Effective November 16, 2026 | https://www.nasdaq.com/articles/vnet-group-inc-appoints-fuqiang-wang-board-directors-effective-november-16-2026
  • N5 | 2026-11-16 | www.nasdaq.com | Prelude Therapeutics Incorporated Reports Third Quarter 2026 Financial Results | https://www.nasdaq.com/articles/prelude-therapeutics-incorporated-reports-third-quarter-2026-financial-results
  • N6 | 2026-08-17 | www.nasdaq.com | Cloudflare CEO Says the Internet Is Changing Exponentially | https://www.nasdaq.com/articles/cloudflare-ceo-says-internet-changing-exponentially
  • N7 | 2026-08-17 | www.nasdaq.com | Mastercard CEO: Cybersecurity Is Our Fastest-Growing Business | https://www.nasdaq.com/articles/mastercard-ceo-cybersecurity-our-fastest-growing-business
  • N8 | 2026-08-17 | www.nasdaq.com | Home Depot's Customer Transactions Have Fallen for 5 Straight Quarters | https://www.nasdaq.com/articles/home-depots-customer-transactions-have-fallen-5-straight-quarters
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine